| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.56B | 7.79B | 7.05B | 8.18B | 9.06B |
| Gross Profit | 1.50B | 1.34B | 850.17M | 429.54M | 351.29M |
| EBITDA | 1.71B | 443.80M | -1.08B | -1.37B | -668.37M |
| Net Income | -936.25M | -1.97B | -2.18B | -2.66B | -1.59B |
Balance Sheet | |||||
| Total Assets | 26.74B | 17.59B | 15.07B | 17.32B | 21.08B |
| Cash, Cash Equivalents and Short-Term Investments | 6.12B | 2.74B | 2.26B | 4.67B | 6.71B |
| Total Debt | 6.47B | 5.91B | 1.72B | 1.69B | 1.62B |
| Total Liabilities | 17.42B | 12.09B | 7.82B | 7.73B | 9.59B |
| Stockholders Equity | 9.32B | 5.17B | 6.89B | 8.80B | 10.60B |
Cash Flow | |||||
| Free Cash Flow | -941.34M | -3.05B | -2.13B | -1.25B | -1.44B |
| Operating Cash Flow | 3.80B | 628.42M | -169.07M | 188.97M | -708.87M |
| Investing Cash Flow | -4.53B | -3.62B | -673.19M | -32.87M | -421.62M |
| Financing Cash Flow | 4.18B | 3.26B | -227.85M | -1.15B | 2.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$947.31M | 4.89 | 23.35% | 9.81% | 2.06% | 2.52% | |
70 Outperform | HK$25.61B | ― | 19.13% | ― | -2.36% | 73.71% | |
62 Neutral | HK$5.32B | 4.97 | 6.30% | 3.47% | -5.00% | -79.97% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$35.53B | -35.61 | -13.37% | ― | 22.96% | 56.71% | |
52 Neutral | HK$3.82B | ― | -0.52% | 3.10% | -10.44% | ― | |
49 Neutral | HK$11.00B | -8.46 | -8.60% | ― | 30.43% | -853.39% |